z-logo
open-access-imgOpen Access
KDM5A regulates the growth and gefitinib drug resistance against human lung adenocarcinoma cells
Author(s) -
Hong Wu,
Lidong Xu,
Xun Hu
Publication year - 2022
Publication title -
3 biotech
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.557
H-Index - 37
eISSN - 2190-572X
pISSN - 2190-5738
DOI - 10.1007/s13205-021-03018-w
Subject(s) - adenocarcinoma , cancer research , downregulation and upregulation , gene knockdown , gene silencing , gefitinib , lung cancer , cell growth , apoptosis , cell culture , biology , medicine , cancer , pathology , gene , biochemistry , genetics , epidermal growth factor receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom